BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8060772)

  • 1. Tumor-induced osteomalacia.
    Hewison M
    Curr Opin Rheumatol; 1994 May; 6(3):340-4. PubMed ID: 8060772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic osteomalacia--a complex dance of factors.
    Carpenter TO
    N Engl J Med; 2003 Apr; 348(17):1705-8. PubMed ID: 12711747
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor-induced rickets/osteomalacia].
    Fukumoto S
    Nihon Rinsho; 2006 Jun; Suppl 2():96-9. PubMed ID: 16817359
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-induced osteomalacia.
    Jan de Beur SM
    JAMA; 2005 Sep; 294(10):1260-7. PubMed ID: 16160135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor-induced rickets/osteomalacia].
    Fukumoto S
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():523-8. PubMed ID: 16279694
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal phosphate--wasting disorders in childhood.
    Ward LM
    Pediatr Endocrinol Rev; 2005 Feb; 2 Suppl 3():342-50. PubMed ID: 16456503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia.
    Fukumoto S; Takeuchi Y; Nagano A; Fujita T
    Bone; 1999 Sep; 25(3):375-7. PubMed ID: 10495143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor-induced hypophosphatemic osteomalacia].
    Ito N; Fukukmoto S
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):731-6. PubMed ID: 17506312
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting--a case report and review of the literature.
    Woznowski M; Quack I; Stegbauer J; Büchner N; Rump LC; Schieren G
    Clin Nephrol; 2008 Nov; 70(5):431-8. PubMed ID: 19000546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor(s) induced osteomalacia--a curious case of double trouble.
    Sahoo J; Balachandran K; Kamalanathan S; Das AK; Patro DK; Halanaik D; Badhe B
    J Clin Endocrinol Metab; 2014 Feb; 99(2):395-8. PubMed ID: 24297794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
    Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
    Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: a perPHEXing problem.
    Quarles LD; Drezner MK
    J Clin Endocrinol Metab; 2001 Feb; 86(2):494-6. PubMed ID: 11157997
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases.
    Bosman A; Palermo A; Vanderhulst J; De Beur SMJ; Fukumoto S; Minisola S; Xia W; Body JJ; Zillikens MC
    Calcif Tissue Int; 2022 Oct; 111(4):367-379. PubMed ID: 35857061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autosomal dominant hypophosphatemic rickets/osteomalacia].
    Tanaka H
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():529-33. PubMed ID: 16279695
    [No Abstract]   [Full Text] [Related]  

  • 15. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired hypophosphatemic osteomalacia associated with multiple myeloma.
    Narvaez J; Domingo-Domenech E; Narvaez JA; Nolla JM; Valverde J
    Joint Bone Spine; 2005 Oct; 72(5):424-6. PubMed ID: 16112595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenous osteomalacia.
    Ghosh S; Sinha R; Bandyopadhyay R; Malhotra M
    J Cancer Res Ther; 2009; 5(3):210-2. PubMed ID: 19841566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
    Alonso G; Varsavsky M
    Endocrinol Nutr; 2016 Apr; 63(4):181-6. PubMed ID: 26718193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.